Blue Marlin Therapeutics, Inc.
CHARLOTTESVILLE, VA · Founded 2025 · CIK 0002092364 · Biotech · Private
Programmable in vivo immune-cell therapies using engineered cells that can be controlled post-administration
bluemarlin.bio →- Grants
- —
- No SBIR or STTR on record
- Sector median: 1
- Raised
- $100K
- 1 Form D · Oct 2025
- 12 months since last filing
- Contracts
- —
- No federal contracts on record
- Patents
- 9
- 0 granted · 9 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓20252026
| Date | Event | Source | Amount |
|---|---|---|---|
| Private capital raised | Form D · SEC | $100,000 |
Form D · SEC
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 2656 | nVector, Inc. | — | $125K |
| 2657 | Sustained Therapeutics Inc. | — | $100K |
| 2658 | GALIBRA NEUROSCIENCE, INC. | — | $100K |
| 2659 | Blue Marlin Therapeutics, Inc. | — | $100K |
| 2660 | CINDER BIOLOGICAL, INC. | — | $100K |
| 2661 | Nano Pharmasolutions Inc. | — | $75K |
| 2662 | Normunity | — | — |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Founders & Team
- Paul ManningExecutive Officer
- Sean StalfortExecutive Officer
Patents
- Mobile Genetic Elements From Eptesicus Fuscusapplication
- Mobile Elements And Chimeric Constructs Thereofapplication
- Transposition-based Therapiesapplication
- Compositions And Methods For Treatment Of Inherited Macular Degenerationapplication
- Compositions And Methods For Treatment Of Cystic Fibrosisapplication
- Myotis Lucifugus Transposase Engineeringapplication
- Compositions And Methods Of Using Gene Coding For Treating Ocular Diseaseapplication
- Myotis Lucifugus Transposase Engineeringapplication
- Mobile Genetic Elements From Myotis Myotisapplication
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.